Medications Development for Drug Abuse Disorders
Completed · Phase 1/Phase 2
Conditions studied: Opioid Related Disorders, Opioid Dependence, Opioid Addiction
In brief
This is a study of tramadol as an agent for short-term opioid withdrawal treatment. A randomized, double blind clinical trial comparing the efficacy and safety of tramadol to clonidine and buprenorphine in the short-term treatment of opioid withdrawal will be conducted. Opioid dependent participants will be treated on a residential unit. The primary outcome measure is opioid withdrawal symptoms.
Key facts
- Study ID
- NCT01188421
- Run by
- Johns Hopkins University
- People needed
- 106
- Starts
- 2010-10-01
- Expected to finish
- 2015-06-01
- Last updated by the study team
- 2017-07-06
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Johns Hopkins University (BPRU) Bayview Campus — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.